Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Piracetam vs Pramiracetam: their evidence isn't directly comparable (one is unscored); they're alternatives for improve memory & learning — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Piracetam wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
1 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Piracetam and Pramiracetam have evidence — compare verdict strength side-by-side.
1200-4800mg daily in divided doses
Divided into 2-3 doses, Morning and early afternoon
Piracetam powder or capsules
Commonly 400-1200mg/day in divided doses (no robustly validated regimen)
Morning
Pramiracetam
2-4 weeks
1-2 weeks
Ongoing
First few days
Weeks
Throughout use
N/A
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Piracetam for reducing the incidence of painful sickle cell disease crises
The Cochrane database of systematic reviews (2016) · Meta analysis · n=169
Cochrane review of three randomised trials with 169 people with sickle cell disease comparing oral piracetam with placebo or standard care.
Treatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trials
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry (2023) · Meta analysis · n=243
Compared with placebo, high-dose oxytocin (72 international units) was associated with the greatest improvement in patients' neuropsychiatric symptoms (SMD = -1.17, 95% CIs = -2.25 to -0.08, z = -2.10, p = 0.035).
Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia.
Brain Inj (1991) · Rct
Double-blind placebo-controlled study of pramiracetam 400 mg three times daily in males with brain-injury-related cognitive deficits
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.
Neurology (1991) · Rct · n=10
Two-phase, placebo-controlled, enrichment-type trial in 10 probable-Alzheimer's patients
Piracetam and other structurally related nootropics.
Brain Res Brain Res Rev (1994) · Review
Comprehensive review of piracetam-class nootropics (1965-1992), including pramiracetam
Piracetam has gradable evidence while Pramiracetam has insufficient evidence to score and wins in 2 of 3 categories.
For improve memory & learning, Pramiracetam has a higher relevance score (26 vs 20).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.